Biotech/Biomedical/Health News

Monday, May 20, 2013

• Cordis Showcases Cardiovascular Innovations at EuroPCR 2013 --- FREMONT, Calif.
  Posted at 11:05 PM
  

  Cordis Corporation, a global leader in innovative technology for cardiovascular interventions, will introduce the two latest additions to its portfolio of cardiovascular solutions at EuroPCR 2013, 21-24 May in Paris. EuroPCR is Europe’s largest meeting for interventional cardiovascular medicine. ... read more
• The 14th Annual BioEquity Europe Conference Features 96 Innovator Companies With Differentiated Products, Upcoming Milestones and Partner-Ready Assets --- REDWOOD CITY, CA
  Posted at 5:21 PM
  

  REDWOOD CITY, CA -- (Marketwired) -- 05/20/13 -- BioCentury, EBD Group and the Biotechnology Industry Organization (BIO) will convene the 14th Annual BioEquity Europe conference in Stockholm, Sweden on Wednesday, May 22, and Thursday, May 23, at the Sheraton Stockholm Hotel. Over 500 life science investment professionals and pharmaceutical business development and licensing executives already have pre-registered. Walk-up registration is available at the Sheraton Stockholm Hotel starting at 7:00 a.m. on May 22. BioEquity Europe showcases a full slate of ... read more
• Ad Manager for Ad Management and Banner Management --- LOS ANGELES, May 20, 2013
  Posted at 5:01 PM
  Ad Space Platform announces the release of its new ad management platform which is aimed at being one of the most advanced one-stop shop platforms that can accommodate all your ad space management and banner management needs and it also allows you to buy ads and sell ads as well! This new platform basically allows any website owner, mobile web ad space owner, or even people with Twitter pages to manage and monetize their ad spaces from one easy to ... read more
• Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial --- PASADENA, Calif.
  Posted at 3:46 PM
  Multiple targets, highly effective, breakthrough therapy for ALS sufferers may now be within reach. Winston Ko, the CEO of Genervon Biopharmaceuticals, will be presenting on Friday at the Neurotech Conference in San Francisco that its endogenous regulatory drug GM604 modulates over 80 ALS related gene targets ... read more
• Cancer Genetics to Attend ASCO Annual Meeting --- RUTHERFORD, N.J.
  Posted at 2:38 PM
  Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, will attend for the first time the 2013 American Society of Clinical Oncology (“ASCO”) Annual Meeting on May 31-June 4, 2013 at McCormick Place in Chicago. CGI will be at stand ... read more
• Holly Hamel Joins Percipio Media, LLC As Director Of Education Services --- CAMBRIDGE, Mass., May 20, 2013
  Posted at 2:15 PM
  Percipio Media, LLC, an emerging leader in the career and education vertical with over 20 million members, announced that Holly Hamel has joined the company as Director of Education Services. Holly brings extensive industry experience and knowledge to Percipio. She most recently served as Director of Sales at All Star Directories, an innovator in education lead generation. Holly also worked previously as Group Sales Manager and Product Marketing Planner at All Star Directories. "We are excited ... read more
• Sensata Technologies listed #7 in The Boston Globe's 2013 list of Top 100 best-performing companies --- ATTLEBORO, Mass., May 20, 2013
  Posted at 2:10 PM
  For the second year in a row, Sensata Technologies, Inc. (NYSE: ST) has been named to The Boston Globe's list of Top 100 best-performing publicly traded corporations based in Massachusetts. (Logo: http://photos.prnewswire.com/prnh/20070227/CLTU192LOGO ) Sensata was listed #7 on this year's list --up from #77 last year-- based on increases in sales, profits, and shareholder returns during 2012. President and Chief Executive Officer Martha Sullivan said, "Sensata is honored to be included in the Globe 100 for the second year in a ... read more
• Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility --- NEW YORK
  Posted at 2:01 PM
  

  Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma (NHL) who are not candidates for intensive high-dose chemotherapy. In ... read more
• ARRIS Brings Transformative Network, Broadband, and Video Solutions to Korean Cable Show --- SUWANEE, Ga., May 20, 2013
  Posted at 2:00 PM
  ARRIS Group, Inc. (Nasdaq: ARRS) will showcase its expanded range of video delivery solutions, including the CCAP-capable E6000(TM) Converged Edge Router (CER) and GT-3 Gigapixel Transcoder at the Korea Cable TV Association (KCTA) Show. The ARRIS world-class portfolio of end-to-end video, data, and voice solutions offers Korean service providers transformative solutions for the smart, simple connected home and next generation multi-screen experiences. E6000 CER - A revolutionary platform to support converged services on broadband networks. The E6000 Converged Edge Router delivers new ... read more
• Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) --- LOS ANGELES, May 20, 2013
  Posted at 2:00 PM
  Today, at the American Psychiatric Association (APA) Meeting in San Francisco, James McGough, M.D., M.S., principal investigator and Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California Los Angeles (UCLA), and director of clinical teaching programs in both Child and Adolescent Psychopharmacology and ADHD at UCLA, presented the results of a Phase I open-label pediatric clinical trial. The study commenced in November 2011 and investigated ... read more
• Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference --- LAVAL, Quebec, May 20, 2013
  Posted at 2:00 PM
  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34(th) Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA. A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. ... read more
• Teleflex Announces Launch of its Next Generation Vascular Positioning System® --- LIMERICK, Pa.
  Posted at 2:00 PM
  

  Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces the launch of the ARROW® VPS G4™Device. The ARROW VPS G4 Device is used in conjunction with the disposable ARROW® VPS® Stylet. ... read more
• DogFriendly.com Recommends Top Last Minute Memorial Day Weekend Pet-Friendly Destinations --- ANCHOR POINT, Alaska, May 20, 2013
  Posted at 1:56 PM
  DogFriendly.com (http://www.dogfriendly.com) today announced its recommendations for pet-friendly vacation destinations for you and your four-legged travel companion for a last minute trip for Memorial Day weekend. Links to the list here: http://dogfriendly.com/dognews/?p=2838 Dogs love summer vacation, as it offers them the opportunity to join you exploring new places and the weather is usually more supportive of outdoor activities. The places recommended here are very dog friendly and are convenient to most areas of the United States and Canada. All ... read more
• The John A. Hartford Foundation Awards Five Grants for Depression Care to Clinics in Western States and Alaska --- NEW YORK, NY
  Posted at 1:47 PM
  

  NEW YORK, NY--(Marketwired - May 20, 2013) - To improve care for depression -- one of the most common and disabling but under-diagnosed and ineffectively treated health conditions -- the John A. Hartford Foundation, an intermediary of the Corporation for National and Community Service, will award grants totaling $1.94 million to five non-profit community health clinics in the WWAMI (Washington, Wyoming, Alaska, Montana, Idaho) ... read more
• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Websense, Inc. - WBSN --- NEW YORK, May 20, 2013
  Posted at 1:42 PM
  Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Websense, Inc. ("Websense" or the "Company") (NASDAQ: WBSN) (ISIN: US9476841062) (CUSIP: 947684106) concerning the proposed acquisition of Websense by Vista Equity Partners LLC in a transaction valued at approximately $900 million in cash. The investigation concerns whether the Websense directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Websense shareholders ... read more
• The Elite Web Group Sets A New Standard For Internet Marketing In The Small - Medium Business Community Throughout The USA --- FORT LAUDERDALE, Fla., May 20, 2013
  Posted at 1:26 PM
  The Elite Web Group, a premier internet marketing solutions provider announced wide acceptance of their turn-key internet marketing plans which were recently introduced for small and medium sized companies. These programs were previously reserved for Elite's larger and corporate clients, but they recognized a similar need within smaller companies. The staff and management at Elite are elated by the widespread interest generated by their unique products and services. Lee Roth, Public Relations manager at Elite stated, "We knew ... read more
• NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock --- BEDMINSTER, N.J.
  Posted at 1:21 PM
  

  NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares in the offering are to be sold by NPS. J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC ... read more
• Impax Board of Directors Establishes Compliance Committee --- HAYWARD, Calif.
  Posted at 1:05 PM
  

  Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its Board of Directors has established a Compliance Committee composed of three independent directors to provide oversight for all activities of the Company related to the U.S. Food and Drug Administration (FDA) warning letter for the Hayward site ... read more
• ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock --- SAN DIEGO
  Posted at 1:01 PM
  

  ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the completion of an underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the full exercise of an option to purchase additional shares previously granted to the underwriters. All of the shares ... read more
• Dodge Brand Launches New TV Commercial and Social Gaming Sweepstakes in Conjunction with Syfy and Trion Worlds 'Defiance' Partnership --- AUBURN HILLS, Mich., May 20, 2013
  Posted at 12:55 PM
  AUBURN HILLS, Mich., May 20, 2013 -- Co-branded television spot launches May 20, coinciding with first appearance of Dodge Chargers as hero vehicles in the 'Defiance' TV program airing Mondays at 9 p.m. on Syfy -- 30-second 'Dodge Charger | Defiance' ad follows the vehicle's endurance from present day to the ... read more